CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 16:27 UTC

The Annexure

Desk› Healthcare› Sanofi India Ltd

Sanofi India Ltd

BSE 500674 SANOFI INE058A01010
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

24 filings · 11 material · busiest 2026-07-23 and 2026-08-04

What it files

General7 Change in Management3 Analyst / Investor Meet2 Concall Transcript1 Investor Presentation1 Newspaper Publication1 Results1 Board Outcome1

Filings

24 in the window

  1. 13 August 2026

    General

    Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Kindly refer the attachment

    Company Update / General View filing →

  2. 11 August 2026

    General

    Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Kindly refer the attachment

    Company Update / General View filing →

  3. 10 August 2026

    Concall Transcript

    Earnings Call Transcript

    Kindly refer the attachment.

    Company Update / Earnings Call Transcript View filing →

  4. 6 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Kindly refer the attachment

    Company Update / Analyst / Investor Meet View filing →

  5. 5 August 2026

    Investor Presentation

    Investor Presentation

    Kindly refer the attachment

    Company Update / Investor Presentation View filing →

  6. 5 August 2026

    Newspaper Publication

    Newspaper Publication

    Kindly refer the attachment

    Company Update / Newspaper Publication View filing →

  7. 4 August 2026

    Results

    Unaudited Financial Results For The Quarter And Half Year Ended 30Th June 2026

    Kindly refer the attachment

    Result / Financial Results View filing →

  8. 4 August 2026

    Board Outcome

    Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended 30Th June 2026

    Kindly refer the attachment

    Board Meeting / Outcome of Board Meeting View filing →

  9. 4 August 2026

    Press Release

    Press Release / Media Release

    Kindly refer the attachment

    Company Update / Press Release / Media Release View filing →

  10. 4 August 2026

    General

    Re-Constitution Of The Committees Of The Company

    Kindly refer the attachment

    Company Update / General View filing →

  11. 4 August 2026

    General

    Intimation Under Regulation 30(5) Of The Listing Regulations

    Kindly refer the attachment

    Company Update / General View filing →

  12. 31 July 2026

    Change in Management

    Change in Management

    Kindly refer the attachment

    Company Update / Change in Management View filing →

  13. 23 July 2026

    Change in Directorate

    Change in Directorate

    Kindly refer the attachment

    Company Update / Change in Directorate View filing →

  14. 23 July 2026

    Change in Management

    Change in Management

    Kindly refer the attachment

    Company Update / Change in Management View filing →

  15. 23 July 2026

    KMP

    Resignation of Chief Financial Officer (CFO)

    Kindly refer the attachment

    Company Update / Resignation of Chief Financial Officer (CFO) View filing →

  16. 23 July 2026

    Resignation

    Resignation of Director

    Kindly refer the attachment

    Company Update / Resignation of Director View filing →

  17. 23 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Kindly refer the attachment.

    Company Update / Analyst / Investor Meet View filing →

  18. 20 July 2026

    Board Meeting

    Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter And Half Year Ended 30Th June 2026.

    Sanofi India Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve the Unaudited Financial Results ....

    Board Meeting / Board Meeting View filing →

  19. 7 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Please find enclosed certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June 2026.

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  20. 3 July 2026

    General

    Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Please find enclosed disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

    Company Update / General View filing →

  21. 26 June 2026

    Trading Window

    Closure of Trading Window

    Kindly refer the attachment

    Insider Trading / SAST / Closure of Trading Window View filing →

  22. 24 June 2026

    General

    Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Please find enclosed disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

    Company Update / General View filing →

  23. 9 June 2026

    General

    Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Please find enclosed disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

    Company Update / General View filing →

  24. 3 June 2026

    Change in Management

    Change in Management

    Appointment of Senior Management Personnel of the Company

    Company Update / Change in Management View filing →